Merck & Co.

MRKNYSE United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$372.321 B

$150.91 +0.94%

Close of 22 Sept 2026

Revenue

$65.0B

#63 by revenue

Earnings

$18.3B

#26 by earnings

Shares outstanding

2,467,171,638

Latest filing cover page

P/E ratio

20.4

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#2Johnson & JohnsonJNJ$648.7B
#3AbbVieABBV$468.7B
#4Merck & Co.MRK$372.3B
#5NovartisNVS$269.6B
#6AstrazenecaAZN$261.1B

What if Merck & Co. were worth as much as…

Open the what-if tool →

Gold $30.2T

$12,254.51

Per share 81.2× higher

Bitcoin $1.74T

$705.93

Per share 4.68× higher

Nvidia $5.52T

$2,235.66

Per share 14.8× higher

Or at a round number

$500.0B $1.00T $2.00T $5.00T

Where these numbers come from

Share counts and financials for Merck & Co. are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.